NSD2 directly regulates the transcriptional activation of ERN1 through the demethylation of histone H3 at lysine 36 (H3K36me2), thereby activating the ERN1–JNK axis to exacerbate intestinal barrier impairment and subsequently promote NASH progression. The gene discussed is MAPK8; the disease is metabolic dysfunction-associated steatohepatitis.